✦ LIBER ✦

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

✍ Scribed by Hijiya, N; Gaynon, P; Barry, E; Silverman, L; Thomson, B; Chu, R; Cooper, T; Kadota, R; Rytting, M; Steinherz, P; Shen, V; Jeha, S; Abichandani, R; Wai Eric, Chi

Book ID: 118675787
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 248 KB
Volume: 23
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2009.185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

A phase I and pharmacodynamic study of s

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia

✍ Brenda W Cooper; Erin Donaher; Hillard M Lazarus; Sylvan B Green; David M Gosky; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 863 KB

A Phase I Trial of High-Dose Clofarabine

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

✍ Shivani Srivastava; David Jones; Lisa L. Wood; Jennifer E. Schwartz; Robert P. N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 324 KB

A phase I study of vorinostat in combina

A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia

✍ Tapan M. Kadia; Hui Yang; Alessandra Ferrajoli; Sirisha Maddipotti; Claudia Schr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Phase 1 dose-escalation trial of clofara

Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias

✍ Amer M. Zeidan; Rebecca M. Ricklis; Hetty E. Carraway; Hyun D. Yun; Jacqueline M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

High-dose idarubicin in combination with

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

✍ Alessandra Tedeschi; Marco Montillo; Elena Strocchi; Anna Maria Cafro; Elisabett 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 338 KB